Michael D. Greenberg

Photo of Michael Greenberg
Director, RAND Center for Corporate Ethics and Governance; Senior Behavioral Scientist; Professor, Pardee RAND Graduate School
Pittsburgh Office


J.D., Harvard Law School; Ph.D. in clinical psychology, Duke University

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email media@rand.org.

More Experts


Michael Greenberg is a senior behavioral scientist at the RAND Corporation, director of the RAND Center for Corporate Ethics and Governance (CCEG), and a professor at the Pardee RAND Graduate School. He is a lawyer and a clinical psychologist by training.

Greenberg's work at RAND has included empirical research projects in areas including civil justice, law and business, health care, and national security. He has led or co-led projects at RAND in all of these areas; examples of his work include studies on fair value accounting and systemic risk, medical malpractice litigation and hospital-based patient safety, and the impact of the financial collapse on the civil justice system.

In his role as director of CCEG, Greenberg leads RAND efforts in developing new research and pathbreaking symposium events designed to contribute to better policy on corporate ethics, governance, and regulatory issues. Greenberg's recent activities have included hosting a conference on corporate political spending policies and compliance; conducting research on international law and practice related to armed drones and targeted killing; and writing a conference proceedings report on problems in court system financing across the United States.

Greenberg worked as an attorney at Ropes & Gray, a large Boston law firm, prior to joining RAND. He received his J.D. from Harvard Law School and his Ph.D. in clinical psychology from Duke University.

Concurrent Non-RAND Positions

Adjunct Professor, University of Pittsburgh Schools of Law and Medicine; Adjunct Instructor, Heinz College of Public Policy, Carnegie Mellon University

Recent Projects

  • Symposium Conference: Transforming Compliance: Emerging Paradigms for Boards, Management, Compliance Officers, and Government
  • Fair Value Accounting and Systemic Risk: A Review of Issues and Options
  • Who Pays for Justice? Perspectives on State Court System Financing and Governance
  • Patient Safety and Medical Malpractice Redux: Examining Evidence from Three Western States
  • Symposium Conference: Culture, Compliance, and the C-Suite: How Executives, Boards, and Policymakers Can Better Safeguard Against Misconduct at the Top

Selected Publications

Michael D. Greenberg and M. Susan Ridgely, "Clinical Decision Support and Malpractice Risk," Journal of the American Medical Association, 306:90-91, 2011

Michael D. Greenberg, For Whom the Whistle Blows: Advancing Corporate Compliance and Integrity Efforts in the Era of Dodd-Frank, RAND Corporation (CF-290-CCEG), 2011

Michael D. Greenberg, Directors as Guardians of Ethics and Compliance in the Corporate Citadel: What the Policy Community Needs to Know, RAND Corporation (CF-277-CCEG), 2010

Michael D. Greenberg, "On the Shoulders of Giants: Directors as Pillars of Ethics and Rectitude in the Corporation," Corporate Finance Review, 15, 2010

Michael D. Greenberg et al., "Corporate Governance in China: A Tale of Rapid Change," Corporate Finance Review, 13, 2009

Michael D. Greenberg, M. Susan Ridgely and Richard J. Hillestad, "Crossed Wires: How Yesterday's Privacy Rules Might Undercut Tomorrow's Nationwide Health Information Network," Health Affairs, 28(2):450-452, 2009

Michael D. Greenberg, Amelia M. Haviland, Yu Hao, and Donna O. Farley, "Safety Outcomes in the United States: Trends and Challenges in Measurement," Health Services Research, 44(2p2):739-55, 2009

Michael D. Greenberg, "The Fault Lies Not in Our Stars, But in Ourselves: Energizing Compliance and Ethics in U.S. Firms," Corporate Finance Review, 14, 2009

Honors & Awards

  • Named to the NACD Directorship 100, National Association of Corporate Directors
  • Thomas Lord Distinguished Scholar, RAND Institute for Civil Justice
  • RAND Silver Medal Award, RAND Corporation, Office of the President


  • A doctor typing on a computer keyboard

    A Unique Identifier Could Protect Patient Privacy

    The policy debate about unique patient identifier numbers should determine the best approach for reconciling two goals: optimizing the privacy and security of health information and making record matching as close to perfect as is practical.

    Feb 3, 2016 STAT

  • Group of people discussing a business plan in a distant office with a conference table in the foreground

    Boards, Compliance and Reputation: Diving Shallow Versus Diving Deep

    Basic questions have been raised about the evolving role of boards, at a time when scandal and perceptions of corporate opportunism have resulted in a loss of public trust in the business community, writes Michael Greenberg.

    May 21, 2013 Financier Worldwide

  • Could Liability Concerns Derail Clinical Decision Support?

    Computerized clinical decision support (CDS) systems have been developed to enhance physician decisionmaking and reduce the incidence of avoidable medical errors. Drug-drug interaction warnings are a mainstay of CDS systems, but they give rise to a fundamental problem that limits the utility of the systems to date.

    Jul 6, 2012

  • Clinical Decision Support and Malpractice Risk

    From the standpoint of policy makers, the basic challenge is to ensure that liability concerns do not derail the clinical value of new CDS technology, write Michael Greenberg and M. Susan Ridgely.

    Jul 6, 2011 The Journal of the American Medical Association

  • How Whistleblower Rule Enables Corporate Compliance

    The kerfuffle over Dodd-Frank conceals broad agreement that corporate fraud and misconduct are bad and that internal compliance mechanisms are intended to protect companies as well the community at large from bad behavior, write Michael Greenberg and Donna Boehme.

    Jun 14, 2011 Bloomberg Government